Market Size in 2021 | Market Forecast in 2028 | CAGR (in %) | Base Year |
---|---|---|---|
USD 23,542.80 million | USD 41,029.65 million | 8.24% | 2021 |
The global neonatal thermoregulation market size was worth USD 23,542.80 million in 2021 and is estimated to grow to USD 41,029.65 million by 2028, with a compound annual growth rate (CAGR) of approximately 9.70 percent over the forecast period. The report analyzes the neonatal thermoregulation market's drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the neonatal thermoregulation market.
Neonatal thermoregulation is a function strongly influenced by physical immaturity, the severity of illness, and other environmental factors. Newborns, especially premature babies, are often at risk for hypothermia within the first 12 hours after birth. During hypothermia, infants lose body heat by four pathways: convection, radiation, conduction, and evaporation. Once the heat is lost, the infant's metabolic system is affected. Devices such as incubators and bottle warmers are widely used to avoid harm to the infant. The rapidly increasing birth rate globally is expected to drive market growth during the forecast period. Furthermore, the availability of state-of-the-art neonatal care facilities is expected to provide significant growth opportunities for companies operating in the global neonatal thermoregulation market during the forecast period.
Request Free SampleCOVID-19 Impact:
The COVID-19 pandemic has impacted the businesses of neonatal thermoregulation. The COVID-19 pandemic spread throughout the world as strict lock-downs are implemented by governments and shut down companies. Thus, the movement of people is restricted during the covid-19 pandemic; the global neonatal thermoregulation market is likely to be impacted considerably during the forecast period. Besides that, the uncertain use of these neonatal thermoregulation devices affected the market growth during the pandemic.
The increasing number of newborns aids the global market growth
Several factors will drive the growth of the global neonatal thermoregulation market in the coming years. With the number of newborns increasing, the devices used to draw blood and monitor babies are growing. More and more companies are focusing on developing social devices so that they can be helped to treat different conditions of babies. It is already aware of the devices available in the market. The soaring birth rate in many parts of the world, especially in emerging countries, is estimated to drive the growth of the global market in the coming years.
The high-risk involvement may hamper the global market growth
The key restraints for the global neonatal thermoregulation market are the potential risks in infants due to heaters. For instance, the American Academy of Pediatrics (AAP) has stated that the most severe complication of radiant heater use is extreme hyperthermia, which can result from improper use or deviation. Sensor probe, resulting in death or permanent neurological damage in the infant.
The increasing development by market players brings up several growth opportunities
Major companies are also developing intelligent incubators upgraded with advanced technology that can be used for premature babies. Innovative and advanced incubators are created by different manufacturers to protect infants from infection, noise, and cold and can be monitored, providing oxygen while maintaining balance by liquid and drug. Therefore, innovation in product development helps to increase the adoption of neonatal thermoregulation globally.
The global neonatal thermoregulation market is segregated based on product type, modality, end-user, and region.
By product type, the market is divided into warmer, neonatal incubators, and neonatal cooling systems. Among these, the warmer segment dominated the market, accounting for a significant percentage of global sales due to the increasing number of newborns globally.
By end-user, the market is bifurcated into hospitals, pediatric, and neonatal intensive care units, nursing homes, and others. Over the forecast period, the hospital segment is expected to develop faster.
Report Attributes | Report Details |
---|---|
Report Name | Neonatal Thermoregulation Market Research Report |
Market Size in 2021 | USD 23,542.80 million |
Market Forecast in 2028 | USD 41,029.65 million |
Growth Rate | CAGR of 8.24% |
Number of Pages | 214 |
Key Companies Covered | GENERAL ELECTRIC COMPANY, Natus Medical Incorporated, Inspiration Healthcare Group plc., Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, International Biomedical Ltd., Atom Medical Corporation, Fanem Ltda, and Novos Medical Systems. |
Segments Covered | By Product Type, By Modality, By End-user, And By Region |
Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
Base Year | 2021 |
Historical Year | 2016 to 2020 |
Forecast Year | 2022 - 2028 |
Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The presence of market players and advancements help North America dominate the global market
In 2021, North America is expected to dominate the global neonatal thermoregulation market with a well-developed healthcare industry. Government involvement in raising awareness about infant diseases drives the market's growth. For example, the U.S. government has programs such as the Health Resources and Services Administration (HRSA) Genetic Disorders Program and the Screening Quality Assurance Program. Thus, such government and NGOs' initiatives and programs support the market's growth. Europe is expected to occupy the second position in the global market. The market development in this region is due to the availability of funding sources for research.
Asia-Pacific is expected to be the fastest growing region in the market due to the presence of a vast patient population and continuously growing economies. According to a report published by the International Journal of Social and Development Concern, in Malaysia, the growth rate of public primary and secondary care facilities has decreased in recent years. It is not keeping pace with rapid urbanization. As such, these factors are holding back the growth of this regional market. In contrast, the Middle East and Africa have the smallest market share.
Some of the main competitors dominating the global neonatal thermoregulation market include
By Product Type
By Modality
By End-user
By Region
FrequentlyAsked Questions
Several factors will drive the growth of the infant thermostat market in the coming years. With the number of newborns increasing, the devices used to draw blood and monitor babies are growing. More and more companies are focusing on developing social devices so that they can be helped to treat different conditions of babies. It is already aware of the devices available in the market. The soaring birth rate in many parts of the world, especially in emerging countries, is estimated to drive the growth of the neonatal air conditioner market in the coming years.
According to a report, the global neonatal thermoregulation market was worth 23,542.80 (USD million) in 2021 and is predicted to grow to 41,029.65 (USD Million) by 2028, with a compound annual growth rate (CAGR) of about 9.70 percent.
North America is expected to dominate the infant air conditioner market with a well-developed healthcare industry. Government involvement in raising awareness about infant diseases drives the market's growth. For example, the U.S. government has programs such as the Health Resources and Services Administration (HRSA) Genetic Disorders Program and the Screening Quality Assurance Program. Thus, such initiatives and programs from the government and NGOs are supporting the market's growth.
Some of the main competitors dominating the global neonatal thermoregulation market include GENERAL ELECTRIC COMPANY, Natus Medical Incorporated, Inspiration Healthcare Group plc., Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Fisher & Paykel Healthcare, International Biomedical, Ltd., Atom Medical Corporation, Fanem Ltda, and Novos Medical Systems.
RelatedNews
HappyClients
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed